14 news items
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
QDEL
10 Jun 24
assured investors that QuidelOrtho was well positioned to maintain a stable high margin revenue stream from its respiratory business. Among other
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, Sonder, QuidelOrtho, and Perion Innovations and Encourages Investors to Contact the Firm
OCGN
PERI
QDEL
7 Jun 24
into an endemic, Defendants assured investors that it was well positioned to maintain a stable high margin revenue stream from its respiratory business
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, and Sharecare and Encourages Investors to Contact the Firm
OCGN
QDEL
SHCR
23 Apr 24
assured investors that it was well positioned to maintain a stable high margin revenue stream from its respiratory business. Among other strategies
QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
QDEL
22 Apr 24
: The litigation is focused on the propriety of QuidelOrtho's past assurances about its preparedness to maintain a stable high margin revenue stream from its
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
QDEL
22 Apr 24
assured investors that QuidelOrtho was well positioned to maintain a stable high margin revenue stream from its respiratory business. Among other
ej776 trn24
OCGN
QDEL
19 Apr 24
-19 transitioning into an endemic, Defendants assured investors that it was well positioned to maintain a stable high margin revenue stream from its
dts318ckq713rzzni9 rof8exylkzvno7rzb42ajzf
QDEL
17 Apr 24
(NASDAQ:QDEL) Securities Class Action: The litigation is focused on the propriety of QuidelOrtho's past assurances about its
0oqej8w2t rtfrxfb7si09ecygj1coe046y4prj8z8k
QDEL
17 Apr 24
) Misled Investors Regarding Demand for its Product According to the complaint, defendants assured investors that QuidelOrtho
nkp0v1bbm0fbpm5lbiao3ty3g oark
QDEL
15 Apr 24
assured investors that QuidelOrtho was well positioned to maintain a stable high margin revenue stream from its respiratory business. Among other
ap7axf9 x2vavdlp6j6wqwatx0n04ahr7viddfzupls2z36k75gbx3m8ppy
QDEL
15 Apr 24
no longer growing exponentially). The Complaint further alleges that despite COVID-19 transitioning into an endemic, Defendants assured investors
0kb90snij7jrj267xk9gsxp9kaz
QDEL
15 Apr 24
). Despite COVID-19 transitioning into an endemic, Defendants assured investors that it was well positioned to maintain a stable high margin revenue
0uq3roqi4d5izfo102npdm9ebhx8zxxwghzkspwqaes95jshf3o8vw
QDEL
13 Apr 24
no longer growing exponentially). Despite COVID-19 transitioning into an endemic, Defendants assured investors that it was well positioned to maintain
wdvl5kqvrsi yb
QDEL
13 Apr 24
(NASDAQ:QDEL) Securities Class Action: The litigation is focused on the propriety of QuidelOrtho's past assurances about its
lsvig1wj2euq4ynjdckbk9pz491 g9abpp
QDEL
12 Apr 24
no longer growing exponentially). Despite COVID-19 transitioning into an endemic, Defendants assured investors that it was well positioned to maintain
- Prev
- 1
- Next